Loading...
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
RGEDF•PNK
Healthcare
Medical - Pharmaceuticals
$27.17
$0.00(0.00%)
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (RGEDF) Financial Performance & Income Statement Overview
Review Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.51%
↑ 6.51%
Operating Income Growth
35.28%
↑ 35.28%
Net Income Growth
50.61%
↑ 50.61%
Operating Cash Flow Growth
140.18%
↑ 140.18%
Operating Margin
29.98%
↑ 29.98%
Gross Margin
68.00%
↑ 68.00%
Net Profit Margin
27.90%
↑ 27.90%
ROE
19.61%
↑ 19.61%
ROIC
18.008%
↑ 18.008%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (RGEDF) Income Statement & Financial Overview
Review Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s (RGEDF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $221.12B | $216.73B | $216.26B | $203.43B |
| Cost of Revenue | $70.02B | $69.06B | $74.14B | $61.23B |
| Gross Profit | $151.10B | $147.67B | $142.12B | $142.20B |
| Gross Profit Ratio | $0.68 | $0.68 | $0.66 | $0.70 |
| R&D Expenses | $29.002B | $24.88B | $22.64B | $22.73B |
| SG&A Expenses | $62.25B | $51.12B | $55.48B | $52.08B |
| Operating Expenses | $91.39B | $76.76B | $79.24B | $78.60B |
| Total Costs & Expenses | -$161.42B | -$145.82B | $153.38B | $139.82B |
| Interest Income | $36.82B | $31.47B | $25.38B | $27.14B |
| Interest Expense | $29.73B | $27.68B | $16.76B | $11.52B |
| Depreciation & Amortization | $13.20B | $13.03B | $8.99B | $11.57B |
| EBITDA | $120.98B | $108.22B | $74.95B | $75.17B |
| EBITDA Ratio | $0.55 | $0.50 | $0.35 | $0.37 |
| Operating Income | $59.71B | $70.91B | $62.88B | $63.61B |
| Operating Income Ratio | $0.27 | $0.33 | $0.29 | $0.31 |
| Other Income/Expenses (Net) | $18.35B | -$25.63B | $11.48B | $18.66B |
| Income Before Tax | $78.05B | $45.28B | $74.36B | $79.23B |
| Income Before Tax Ratio | $0.35 | $0.21 | $0.34 | $0.39 |
| Income Tax Expense | $14.95B | $8.78B | $4.09B | $13.73B |
| Net Income | $63.97B | $37.06B | $70.00B | $68.22B |
| Net Income Ratio | $0.29 | $0.17 | $0.32 | $0.34 |
| EPS | $348.00 | $203.00 | $382.92 | $373.00 |
| Diluted EPS | $348.00 | $203.00 | $382.92 | $373.00 |
| Weighted Avg Shares Outstanding | $183.82M | $182.56M | $182.80M | $182.89M |
| Weighted Avg Shares Outstanding (Diluted) | $183.82M | $182.56M | $182.80M | $182.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan